Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fridland

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|December 3, 1998
Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transportersR V Srinivas, D Middlemas, P Flynn, et al.
Cancer Research|April 1, 1983
Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblastsD K Kalwinsky, A T Look, J Ducore, et al.
Molecular Pharmacology|April 1, 1995
Metabolic diversity and antiviral activities of acyclic nucleoside phosphonatesP Aduma, M C Connelly, R V Srinivas, et al.
Biochemical Pharmacology|August 15, 1989
Regulation of purine deoxynucleoside phosphorylation by deoxycytidine kinase from human leukemic blast cellsJ C Sarup, M A Johnson, V Verhoef, et al.
Cancer Research|May 1, 1980
Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblastsL W Dow, D E Bell, L Poulakos, et al.
The Journal of Infectious Diseases|September 1, 1996
A systemic and cellular model for zidovudine plasma concentrations and intracellular phosphorylation in patientsJ H Rodman, B Robbins, P M Flynn, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1995
Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cellsB L Robbins, J Greenhaw, M C Connelly, et al.
Molecular Pharmacology|July 1, 1997
Intracellular metabolism and action of acyclic nucleoside phosphonates on DNA replicationV M Pisarev, S H Lee, M C Connelly, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1994
Susceptibilities of zidovudine-resistant variants of human immunodeficiency virus type 1 to inhibition by acyclic nucleoside phosphonatesY F Gong, D R Marshall, R V Srinivas, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPAB L Robbins, R V Srinivas, C Kim, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|December 3, 1998
Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transportersR V Srinivas, D Middlemas, P Flynn, et al.
Cancer Research|April 1, 1983
Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblastsD K Kalwinsky, A T Look, J Ducore, et al.
Molecular Pharmacology|April 1, 1995
Metabolic diversity and antiviral activities of acyclic nucleoside phosphonatesP Aduma, M C Connelly, R V Srinivas, et al.
Biochemical Pharmacology|August 15, 1989
Regulation of purine deoxynucleoside phosphorylation by deoxycytidine kinase from human leukemic blast cellsJ C Sarup, M A Johnson, V Verhoef, et al.
Cancer Research|May 1, 1980
Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblastsL W Dow, D E Bell, L Poulakos, et al.
The Journal of Infectious Diseases|September 1, 1996
A systemic and cellular model for zidovudine plasma concentrations and intracellular phosphorylation in patientsJ H Rodman, B Robbins, P M Flynn, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1995
Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cellsB L Robbins, J Greenhaw, M C Connelly, et al.
Molecular Pharmacology|July 1, 1997
Intracellular metabolism and action of acyclic nucleoside phosphonates on DNA replicationV M Pisarev, S H Lee, M C Connelly, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1994
Susceptibilities of zidovudine-resistant variants of human immunodeficiency virus type 1 to inhibition by acyclic nucleoside phosphonatesY F Gong, D R Marshall, R V Srinivas, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPAB L Robbins, R V Srinivas, C Kim, et al.
Pageof 7